TORONTO, April 21,
2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the
"Company") (TSX: HLS), a pharmaceutical company focusing on central
nervous system ("CNS") and cardiovascular markets, announces that
Tim Hendrickson, Chief Financial
Officer, will present at the Bloom Burton & Co. Healthcare
Investor Conference, which takes place Tuesday April 25 - Wednesday April 26, 2023 at
the Metro Toronto Convention Centre, North Building, in downtown
Toronto.
HLS will present on April 25,
2023, at 11:30 a.m. Eastern
Time. The Company's presentation will be webcast at:
https://wsw.com/webcast/bloomburton8/hls.to/3108072. Mr.
Hendrickson will also host one-on-one meetings with investors at
the conference. To request a one-on-one meeting, please contact
your Bloom Burton representative or place a request through the
conference portal.
ABOUT HLS THERAPEUTICS
INC.
Formed in 2015, HLS is a pharmaceutical company focused on the
acquisition and commercialization of late-stage development,
commercial stage promoted and established branded pharmaceutical
products in the North American markets. HLS's focus is on products
targeting the central nervous system and cardiovascular therapeutic
areas. HLS's management team is composed of seasoned pharmaceutical
executives with a strong track record of success in these
therapeutic areas and at managing products in each of these
lifecycle stages. For more information visit:
www.hlstherapeutics.com
ABOUT THE CONFERENCE
The Bloom Burton & Co. Healthcare Investor Conference brings
together U.S., Canadian and international investors who are
interested in the latest developments in the Canadian healthcare
sector. Attendees will have an opportunity to obtain corporate
updates from the premier Canadian publicly traded and private
companies through presentations and private meetings.
ABOUT BLOOM BURTON &
CO.
Bloom Burton & Co. is a firm dedicated to accelerating
returns in the healthcare sector for both investors and companies.
Bloom Burton has an experienced team of medical, scientific,
industry and capital markets professionals who perform a deep level
of diligence, which combined with our creative and entrepreneurial
approach, assists our clients in achieving the right monetization
events. Bloom Burton and its affiliates provide capital raising,
M&A advisory, equity research, business strategy and scientific
consulting, as well as advisory on direct investing, company
creation and incubation services. Bloom Burton Securities Inc. is a
member of the Investment Industry Regulatory Organization of
Canada (IIROC) and is also a
member of the Canadian Investor Protection Fund (CIPF).
SOURCE HLS Therapeutics Inc.